Filing Details
- Accession Number:
- 0001415889-25-008918
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-25 17:15:53
- Reporting Period:
- 2025-03-24
- Filing Date:
- 2025-03-25
- Accepted Time:
- 2025-03-25 17:15:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1472012 | Immunome Inc. | IMNM | Pharmaceutical Preparations (2834) | 770694340 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 2026600 | Philip Tsai | C/O Immunome, Inc. 18702 N. Creek Parkway, Suite 100 Bothell WA 98011 | Chief Technology Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-03-24 | 12,300 | $8.42 | 33,300 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
